• English
  • 简体中文
Login Register
Current Location: Home > FDA Approved Drug Products Feedback Help
-
-
Application Number Application Type Drug Name Active Ingredients Dosage Form/Route Approval Date Company
215942 ANDA CABOZANTINIB CABOZANTINIB TABLET;ORAL 2022-10-27 TEVA PHARMS INC
208692 NDA CABOMETYX CABOZANTINIB S-MALATE TABLET;ORAL 2016-04-25 EXELIXIS INC
203756 NDA COMETRIQ CABOZANTINIB S-MALATE CAPSULE;ORAL 2012-11-29 EXELIXIS